Patents Assigned to Belina Pharma AB
  • Antihistamine for use in treatment of breast cancer
    Patent number: 10456388
    Abstract: Disclosed herein is desloratadine or ebastin for use in treatment of a patient diagnosed with breast cancer. Also disclosed is desloratadine or ebastin for use in treatment of a patient diagnosed with a cancer type susceptible to immunotherapy.
    Type: Grant
    Filed: January 19, 2016
    Date of Patent: October 29, 2019
    Assignee: Belina Pharma AB
    Inventors: Hakan Olsson, Rickard Einefors
  • ANTIHISTAMINE FOR USE IN TREATMENT OF BREAST CANCER
    Publication number: 20180008588
    Abstract: Disclosed herein is desloratadine or ebastin for use in treatment of a patient diagnosed with breast cancer. Also disclosed is desloratadine or ebastin for use in treatment of a patient diagnosed with a cancer type susceptible to immunotherapy.
    Type: Application
    Filed: January 19, 2016
    Publication date: January 11, 2018
    Applicant: Belina Pharma AB
    Inventors: Hakan OLSSON, Rickard EINEFORS